Literature DB >> 22855747

Transforming TB diagnosis: can patients and control programs afford to wait?

Elizabeth A Talbot1, Jean W Pape, Lakshmi Sundaram, Catharina C Boehme, Mark D Perkins.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22855747      PMCID： PMC3414552          DOI： 10.4269/ajtmh.2012.12-0247

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  13 in total

1.  Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system.

Authors:  Doris Hillemann; Sabine Rüsch-Gerdes; Catharina Boehme; Elvira Richter
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

2.  Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?

Authors:  Viral Vadwai; Catharina Boehme; Pamela Nabeta; Anjali Shetty; David Alland; Camilla Rodrigues
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

3.  Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study.

Authors:  Andrea Rachow; Petra Clowes; Elmar Saathoff; Bariki Mtafya; Epiphania Michael; Elias N Ntinginya; Dickens Kowour; Gabriel Rojas-Ponce; Arne Kroidl; Leonard Maboko; Norbert Heinrich; Klaus Reither; Michael Hoelscher
Journal:  Clin Infect Dis       Date:  2012-04-03       Impact factor: 9.079

4.  Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis.

Authors:  Enrico Tortoli; Cristina Russo; Claudio Piersimoni; Ester Mazzola; Paola Dal Monte; Michela Pascarella; Emanuele Borroni; Alessandra Mondo; Federica Piana; Claudio Scarparo; Luana Coltella; Giulia Lombardi; Daniela M Cirillo
Journal:  Eur Respir J       Date:  2012-01-12       Impact factor: 16.671

5.  Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapy.

Authors:  Taiwo O Abimbola; Barbara J Marston; Anand A Date; John M Blandford; Nalinee Sangrujee; Stefan Z Wiktor
Journal:  J Acquir Immune Defic Syndr       Date:  2012-05-01       Impact factor: 3.731

6.  Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study.

Authors:  Mark P Nicol; Lesley Workman; Washiefa Isaacs; Jacinta Munro; Faye Black; Brian Eley; Catharina C Boehme; Widaad Zemanay; Heather J Zar
Journal:  Lancet Infect Dis       Date:  2011-07-19       Impact factor: 25.071

7.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

8.  Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.

Authors:  Catharina C Boehme; Mark P Nicol; Pamela Nabeta; Joy S Michael; Eduardo Gotuzzo; Rasim Tahirli; Ma Tarcela Gler; Robert Blakemore; William Worodria; Christen Gray; Laurence Huang; Tatiana Caceres; Rafail Mehdiyev; Lawrence Raymond; Andrew Whitelaw; Kalaiselvan Sagadevan; Heather Alexander; Heidi Albert; Frank Cobelens; Helen Cox; David Alland; Mark D Perkins
Journal:  Lancet       Date:  2011-04-18       Impact factor: 79.321

9.  Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.

Authors:  Stephen D Lawn; Sophie V Brooks; Katharina Kranzer; Mark P Nicol; Andrew Whitelaw; Monica Vogt; Linda-Gail Bekker; Robin Wood
Journal:  PLoS Med       Date:  2011-07-26       Impact factor: 11.069

10.  Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.

Authors:  Anna Vassall; Sanne van Kampen; Hojoon Sohn; Joy S Michael; K R John; Saskia den Boon; J Lucian Davis; Andrew Whitelaw; Mark P Nicol; Maria Tarcela Gler; Anar Khaliqov; Carlos Zamudio; Mark D Perkins; Catharina C Boehme; Frank Cobelens
Journal:  PLoS Med       Date:  2011-11-08       Impact factor: 11.069
View more
  1 in total

1.  Rapid Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert Assay: A Clinical Study.

Authors:  Deepak Arora; Neerja Jindal; Renu Bansal; Shilpa Arora
Journal:  J Clin Diagn Res       Date:  2015-05-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.